Cyclo Therapeutics (CYTH) Reports Publication of Data from Phase 2 Study of Trappsol Cyclo streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
– Data published in official journal of Molecular Genetics and Metabolism Reports:
Evidence of a change in cholesterol homeostasis in peripheral organs and the brain after the initial infusion
Trappsol® Cyclo™ was detected in the CSF
Completers had an 88.9% improvement in at least two domains of the 17-Domain Niemann-Pick Type C1 Clinical Severity Scale (17D-NPC-CSS)
Improvement in Scale Assessment and Rating of Ataxia (SARA) score for the mean score in 7 of 8 domains at Week 48 compared with baseline
Demonstrated a favorable benefit-risk profile
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Rating) was the target of a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 61,700 shares, an increase of 11.8% from the May 15th total of 55,200 shares. Based on an average daily volume of 137,900 shares, the […]
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Rating) was the recipient of a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 61,700 shares, a growth of 11.8% from the May 15th total of 55,200 shares. Based on an average trading volume of 137,900 shares, the […]
Since the end of the third quarter, we made an initial $2.1 million investment in Cyclo Therapeutics, Inc. and have an agreement to increase our investment by $5 million NEWARK, N.J., June 13, 2023 . | June 13, 2023